-
公开(公告)号：US20240173391A1
公开(公告)日：2024-05-30
申请号：US18552383
申请日：2022-03-25
发明人： Agnete Øvre Fredriksen , Karoline Schjetne , Stine Granum , Audun Trygge Haugen Bersaas , Ina Park Rhee , Siri Brinchmann-Hansen Torhaug
IPC分类号： A61K39/00 , A61K39/395 , A61K45/06 , A61P35/00 , C07K16/28
CPC分类号： A61K39/0011 , A61K39/39541 , A61K45/06 , A61P35/00 , C07K16/2803 , C07K16/2818 , C07K16/2827 , A61K2039/505 , A61K2039/53 , A61K2039/6056 , A61K2039/627
摘要： This invention relates to methods and kits for treating a subject having cancer, e.g. a patient, by administering to the subject an anticancer vaccine in combination with one or more checkpoint inhibitors.
-
公开(公告)号：US20230293650A1
公开(公告)日：2023-09-21
申请号：US17995780
申请日：2021-04-09
CPC分类号： A61K39/0011 , A61P35/00 , A61K2039/53 , A61K2039/6031 , A61K2039/70
摘要： The present invention relates to an individualized therapeutic anticancer vaccine, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine.
-
公开(公告)号：US12059459B2
公开(公告)日：2024-08-13
申请号：US17557988
申请日：2021-12-21
CPC分类号： A61K39/0011 , A61P35/00 , A61K2039/53 , A61K2039/6031 , A61K2039/6056 , A61K2039/627 , A61K2039/64 , A61K2039/70
摘要： The present invention relates to an anticancer vaccine which includes polynucleotides or polypeptides, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine. The vaccine includes a polynucleotide with a nucleotide sequence encoding a targeting unit, a dimerization unit, a first linker and an antigenic unit. The antigenic unit includes from 3 to 50 antigenic subunits separated by a second linker with each antigenic subunit having at least a part of a cancer neoepitope sequence. The vaccine can include a polypeptide encoded by the polynucleotide or a dimeric protein with two polypeptides encoded by the polynucleotide.
-
公开(公告)号：US20240350601A1
公开(公告)日：2024-10-24
申请号：US18738685
申请日：2024-06-10
CPC分类号： A61K39/0011 , A61P35/00 , A61K2039/53 , A61K2039/6031 , A61K2039/6056 , A61K2039/627 , A61K2039/64 , A61K2039/70
摘要： The present invention relates to an anticancer vaccine which includes polynucleotides or polypeptides, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine. The vaccine includes a polynucleotide with a nucleotide sequence encoding a targeting unit, a dimerization unit, a first linker and an antigenic unit. The antigenic unit includes from 3 to 50 antigenic subunits separated by a second linker with each antigenic subunit having at least a part of a cancer neoepitope sequence. The vaccine can include a polypeptide encoded by the polynucleotide or a dimeric protein with two polypeptides encoded by the polynucleotide.
-
公开(公告)号：US20240252625A1
公开(公告)日：2024-08-01
申请号：US18560868
申请日：2022-05-10
CPC分类号： A61K39/35 , A61K39/0008 , A61K45/06 , A61P37/06 , C12N15/86 , C12N2800/107 , C12N2800/60 , C12N2810/851 , C12N2840/206
摘要： The present invention relates to vectors, such as DNA plasmids, comprising multiple nucleic acid sequences engineered to be co-expressed as separate molecules. Such separate molecules include a first polypeptide, wherein the first polypeptide comprises a targeting unit that targets antigen-presenting cells, a multimerization unit, such as dimerization unit, and an antigenic unit comprising one or more T cell epitopes of a self-antigen, an allergen, an alloantigen or a xenoantigen, and one or more immunoinhibitory compounds
-
公开(公告)号：US20220370579A1
公开(公告)日：2022-11-24
申请号：US17557988
申请日：2021-12-21
摘要： The present invention relates to an anticancer vaccine which includes polynucleotides or polypeptides, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine. The vaccine includes a polynucleotide with a nucleotide sequence encoding a targeting unit, a dimerization unit, a first linker and an antigenic unit. The antigenic unit includes from 3 to 50 antigenic subunits separated by a second linker with each antigenic subunit having at least a part of a cancer neoepitope sequence. The vaccine can include a polypeptide encoded by the polynucleotide or a dimeric protein with two polypeptides encoded by the polynucleotide.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.017 秒)
